HopeStage
Back to all studies
Active Not RecruitingNCT05829681

Brain imaging markers and response to two rTMS targets for OCD

About this titleRead the official source — NCT05829681
Device studyAges 18–80United States
The study in practice

Understand this study

Who could participate?

This study is for people with OCD. Listed age limits: 18 years to 80 years. Other eligibility criteria apply.

Listed locations
StanfordSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 14, 2022
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
212
Sponsor
Stanford University
Sponsor type
University
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 18 Years to 80 Years
Official registry ID
NCT05829681
Official title
Show the full official title

Individualized Neuroimaging Biomarkers for Predicting Repetitive Transcranial Magnetic Stimulation (rTMS) Response in Obsessive Compulsive Disorder (OCD)

Recruitment & locations

Not recruiting

Stanford

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Stanford University, a university.

Who can participate?

This study is for people with OCD. Listed age limits: 18 years to 80 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies